The report "Neuromodulation Market by Type (Internal (Deep Brain Stimulation, Vagus Nerve Stimulation), External (Transcranial Magnetic Stimulation)), Application (Parkinsons Disease, Depression, Urine incontinence, Epilepsy, Obesity) - Global Forecast to 2027" is projected to reach USD 10.4 billion by 2027, at a CAGR of 11.8%.
Browse 210 market data Tables and 36 Figures spread through 215 Pages and in-depth TOC on "Neuromodulation Market - Global Forecast to 2027"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/neurostimulation-devices-market-921.html
The internal neuromodulation accounted for the largest share of the neuromodulation market, by type segment.
The global neuromodulation market is segmented into internal neuromodulation and external neuromodulation based on type. Internal neuromodulation accounted for the largest share of the global neuromodulation market. This is mainly due to factors such growing incidence of spinal cord injuries and rising number of people suffering from severe GERD and gastroparesis.
Spinal cord stimulation segment to register the highest growth rate among internal modulation during the forecast period
The global internal neuromodulation market is segmented into spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, and gastric electrical stimulation based on type. The spinal cord stimulation segment accounted for the largest share of the neuromodulation market, owing to the high incidence of chronic pain, and growing incidence of FBSS due to rising number of surgeries each year.
North America is the largest regional market for neuromodulation market
The global neuromodulation market has been segmented into four major regions—North America, Europe, the Asia Pacific, and the Rest of the World. North America dominated the global neuromodulation market. The large share of the North American market is primarily driven by the rising prevalence of chronic diseases, increasing geriatric population, and the rising number of cases of Lyme and Alzheimer’s disease
The major players operating in this market are Medtronic (Ireland), Boston Scientific Corporation (US), Abbott Laboratories (US), and LivaNova (UK).
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441